Regenlab USA Inc.

Regenlab USA Inc. publicly filed a registration statement on Form S-1 on Sep 25, 2026 for a proposed initial public offering on NYSE under the ticker RGNA, and has not yet priced. Underwriters named in the filing: Table of Contents Underwriting StoneX Financial.

RegenLab USA Inc. is the U.S. holding entity of RegenLab, a regenerative medicine company founded in Switzerland. It makes blood-processing devices for platelet rich plasma, PRP and hyaluronic acid combination products, and bone marrow solutions, with manufacturing and R&D sites in New Jersey, Paris and Monthey.

Status

Filed, not priced

Ticker

RGNA

Exchange

NYSE

First filed

Sep 25, 2026

Latest amendment

Sep 25, 2026

Underwriters

Table of Contents Underwriting StoneX Financial

Sector

Biotech & pharma

Country / state

NJ